• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾衰竭患者的动脉硬化及钙拮抗剂的降压反应

Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure.

作者信息

Marchais S J, Boussac I, Guerin A P, Delavaux G, Metivier F, London G M

机构信息

Centre Hospitalier F. H. Manhes Fleury-Mérogis, France.

出版信息

J Cardiovasc Pharmacol. 1991;18 Suppl 5:S14-8.

PMID:1725796
Abstract

The relationship between the presence of arterial calcinosis and the antihypertensive response to calcium blockers was studied in 40 hypertensive patients with end-stage renal failure (ESRF) on chronic hemodialysis, before and during 16 weeks after administration of nitrendipine in monotherapy. In a double-blind, placebo-randomized study, nitrendipine reduced systolic blood pressure regardless of the presence or absence of arterial calcifications. The antihypertensive effects were significantly more pronounced in subjects with aortic calcium deposits in comparison with patients without clinical signs of arteriosclerosis (p less than 0.01). Diastolic blood pressure was significantly reduced only in patients with aortic calcifications, and remained unchanged in subjects with noncalcified aorta. Aortic pulse wave velocity decreased significantly in patients with aortic calcifications (p less than 0.001), but remained unaffected in patients with noncalcified vessels. Multivariate regression analysis showed that antihypertensive action of nitrendipine was correlated with the presence of aortic calcium deposits independently of age or baseline blood pressure levels. The results of the present study indicate that an overt arteriosclerosis as demonstrated by the presence of aortic calcifications on abdominal radiographs is a good indication for use of dihydropiridines in patients with ESRF.

摘要

在40例接受慢性血液透析的终末期肾衰竭(ESRF)高血压患者中,研究了动脉钙化的存在与对钙通道阻滞剂降压反应之间的关系,研究时间为单药使用尼群地平之前以及用药后16周期间。在一项双盲、安慰剂随机研究中,无论有无动脉钙化,尼群地平均可降低收缩压。与无动脉硬化临床体征的患者相比,有主动脉钙沉积的受试者降压效果明显更显著(p<0.01)。仅主动脉钙化患者的舒张压显著降低,无钙化主动脉的受试者舒张压无变化。主动脉钙化患者的主动脉脉搏波速度显著降低(p<0.001),但血管未钙化的患者不受影响。多因素回归分析表明,尼群地平的降压作用与主动脉钙沉积的存在相关,与年龄或基线血压水平无关。本研究结果表明,腹部X线片显示的明显动脉硬化,即主动脉钙化,是ESRF患者使用二氢吡啶类药物的良好指征。

相似文献

1
Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure.终末期肾衰竭患者的动脉硬化及钙拮抗剂的降压反应
J Cardiovasc Pharmacol. 1991;18 Suppl 5:S14-8.
2
Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure.
J Cardiovasc Pharmacol. 1991;18 Suppl 1:S74-8.
3
A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function.
Clin Nephrol. 1995 Jun;43(6):388-91.
4
Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study.西拉普利和尼群地平对老年高血压患者血压、情绪、睡眠及认知功能的影响:一项意大利多中心研究
J Cardiovasc Pharmacol. 1994;24 Suppl 3:S73-7.
5
Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension.氨氯地平和尼群地平单药治疗原发性高血压患者的平行对照试验
J Hypertens Suppl. 1998 Sep;16(4):S43-7.
6
A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.一项关于伊拉地平与螺普利作为单一疗法及联合疗法对慢性肾衰竭合并高血压患者肾功能下降影响的随机双盲对照研究。
Clin Nephrol. 2001 May;55(5):375-83.
7
[Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].[伊拉地平缓释剂型与尼群地平个体内比较的昼夜降压作用及耐受性]
Arzneimittelforschung. 1993 May;43(5):522-5.
8
Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.长效钙通道阻滞剂在血液透析日的降压作用——苯磺酸氨氯地平和硝苯地平控释片的随机交叉试验
Nephron Clin Pract. 2004;97(2):c49-53. doi: 10.1159/000078400.
9
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.缬沙坦联合氢氯噻嗪与氨氯地平单药治疗对伴有其他心血管危险因素的高血压患者的疗效及耐受性比较:VAST研究
Clin Ther. 2005 May;27(5):578-87. doi: 10.1016/j.clinthera.2005.05.006.
10
Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.慢性抗高血压药物治疗下的血压反应:主动脉僵硬度在REASON(培哚普利在控制双盲试验中对动脉僵硬度的逆转作用)研究中的作用
J Am Coll Cardiol. 2009 Feb 3;53(5):445-51. doi: 10.1016/j.jacc.2008.09.046.

引用本文的文献

1
Calcium channel blockers for people with chronic kidney disease requiring dialysis.用于需要透析的慢性肾病患者的钙通道阻滞剂。
Cochrane Database Syst Rev. 2020 Oct 1;10(10):CD011064. doi: 10.1002/14651858.CD011064.pub2.